Literature DB >> 20190160

Total adrenal volume but not testicular adrenal rest tumor volume is associated with hormonal control in patients with 21-hydroxylase deficiency.

Nicole Reisch1, Michael Scherr, Linda Flade, Martin Bidlingmaier, Hans-Peter Schwarz, Ullrich Müller-Lisse, Martin Reincke, Marcus Quinkler, Felix Beuschlein.   

Abstract

CONTEXT: Patients with 21-hydroxylase deficiency (21-OHD) have been shown to develop adrenal adenomas and, in males, testicular adrenal rest tumors (TARTs) at a high percentage.
OBJECTIVE: The aim of this study was to evaluate the interrelation of adrenal masses and TARTs as well as factors stimulating tumor growth of orthotopic and ectopic adrenal tissue in 21-OHD.
DESIGN: In a cross-sectional study, 26 adult male patients with classic 21-OHD (15 salt wasting, 11 simple virilizing; age range, 18-48 yr) were clinically assessed according to their hormonal control. Magnetic resonance imaging of the adrenals (26 of 26) and of the testes (18 of 26) was performed. Adrenal size and morphology was compared to 26 age-matched controls.
RESULTS: Combined adrenal volume of 21-OHD patients was significantly higher (median, 9.3 ml; range, 3.2-124.5 ml) in comparison to controls (median, 7.4 ml; range, 5.5-10.8 ml; P = 0.005). Morphologically, adrenals were classified as normal without nodules in 27% of 21-OHD patients compared to 69% of controls. None of the controls, but 42% of 21-OHD patients had an overall adrenal volume higher than 11 ml. Ten of 18 patients had TARTs with a median volume of 3.3 ml (range, 0.4-21.6 ml). Total adrenal volume and tumor size but not TART volume correlated positively with current parameters of hormonal control (androstenedione, morning 17-OHP in serum, pregnanetriol in 24-h urine; P < 0.001 for each). Baseline ACTH was independent of adrenal and TART volume. There was no correlation of total adrenal or adrenal tumor size with TART volume.
CONCLUSION: These data provide indirect evidence that different factors regulate the growth of orthotopic adrenal tissue and ectopic adrenal remnants in TARTs.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20190160     DOI: 10.1210/jc.2009-1929

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  22 in total

Review 1.  Clinical perspectives in congenital adrenal hyperplasia due to 11β-hydroxylase deficiency.

Authors:  Krupali Bulsari; Henrik Falhammar
Journal:  Endocrine       Date:  2016-12-07       Impact factor: 3.633

2.  Abiraterone acetate to lower androgens in women with classic 21-hydroxylase deficiency.

Authors:  Richard J Auchus; Elizabeth O Buschur; Alice Y Chang; Gary D Hammer; Carole Ramm; David Madrigal; George Wang; Martha Gonzalez; Xu Steven Xu; Johan W Smit; James Jiao; Margaret K Yu
Journal:  J Clin Endocrinol Metab       Date:  2014-04-29       Impact factor: 5.958

Review 3.  Clinical outcomes in the management of congenital adrenal hyperplasia.

Authors:  Henrik Falhammar; Marja Thorén
Journal:  Endocrine       Date:  2012-01-07       Impact factor: 3.633

Review 4.  Nonclassic congenital adrenal hyperplasia due to 21-hydroxylase deficiency: clinical presentation, diagnosis, treatment, and outcome.

Authors:  Henrik Falhammar; Anna Nordenström
Journal:  Endocrine       Date:  2015-06-17       Impact factor: 3.633

5.  Adrenal morphology and associated comorbidities in congenital adrenal hyperplasia.

Authors:  Diala El-Maouche; Fady Hannah-Shmouni; Ashwini Mallappa; Courtney J Hargreaves; Nilo A Avila; Deborah P Merke
Journal:  Clin Endocrinol (Oxf)       Date:  2019-05-07       Impact factor: 3.478

6.  Use of PET/CT with cosyntropin stimulation to identify and localize adrenal rest tissue following adrenalectomy in a woman with congenital adrenal hyperplasia.

Authors:  Melissa K Crocker; Stephanie Barak; Corina M Millo; Stephanie A Beall; Mahtab Niyyati; Richard Chang; Nilo A Avila; Carol Van Ryzin; James Segars; Martha Quezado; Deborah P Merke
Journal:  J Clin Endocrinol Metab       Date:  2012-08-17       Impact factor: 5.958

7.  Management of the adult with congenital adrenal hyperplasia.

Authors:  Richard J Auchus
Journal:  Int J Pediatr Endocrinol       Date:  2010-05-30

Review 8.  Prostate gland development and adrenal tumor in a female with congenital adrenal hyperplasia: a case report and review from radiology perspective.

Authors:  Benjamin Fang; Francis Cho; Wendy Lam
Journal:  J Radiol Case Rep       Date:  2013-12-01

Review 9.  Management of adolescents with congenital adrenal hyperplasia.

Authors:  Deborah P Merke; Dix P Poppas
Journal:  Lancet Diabetes Endocrinol       Date:  2013-11-15       Impact factor: 32.069

Review 10.  The Rise, Fall, and Resurrection of 11-Oxygenated Androgens in Human Physiology and Disease.

Authors:  Adina F Turcu; Aya T Nanba; Richard J Auchus
Journal:  Horm Res Paediatr       Date:  2018-05-09       Impact factor: 2.852

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.